It was displayed that within the TME of GC, H. pylori infection could increase the expression of T cell receptor-inducible costimulatory receptor (ICOS) in pDC and Tregs, suggesting that eradicating therapy for H. pylori might serve as an indirect immune therapy for GC [86]. This evidence concerns the gene ICOS and gastric cancer.